Teva to Present New Data Supporting Safety, Efficacy and Real-World Effectiveness of AUSTEDO® (deutetrabenazine) Tablets at the 2023 HSG Annual MeetingBusiness Wire • 11/02/23
Teva to Provide Second Round of Funding to Clinics in California, Florida and New Jersey as Part of $2 Million Commitment Through Community Routes: Access to Mental Health Care ProgramBusiness Wire • 10/25/23
Teva Phase IV UNITE Study Shows AJOVY® (fremanezumab) Reduced Migraine Attacks and Depression Symptoms in Migraine Sufferers with Major Depressive DisorderBusiness Wire • 10/17/23
Teva Leverages Market-leading Temperature and Theft Tracking from FourKites to Deliver Critical Medicines Around the WorldBusiness Wire • 10/12/23
Teva Leverages Market-leading Temperature & Theft Tracking from FourKites to Deliver Critical Medicines Around the WorldBusiness Wire • 10/12/23
Teva to Host Conference Call to Discuss Third Quarter 2023 Financial Results at 8 a.m. ET on November 8, 2023Business Wire • 10/06/23
Teva Pharma Hooks Sanofi In $1.5 Billion Inflammation Deal. But Shares Tumble.Investors Business Daily • 10/04/23
Sanofi and Teva Announce Exclusive Collaboration to Deliver Inflammatory Bowel Disease TreatmentBusiness Wire • 10/04/23
Press Release: Sanofi and Teva announce exclusive collaboration to deliver inflammatory bowel disease treatmentGlobeNewsWire • 10/04/23
Press Release - Sanofi and Teva announce exclusive collaboration to deliver inflammatory bowel disease treatmentGlobeNewsWire • 10/04/23
Teva Pharmaceutical Industries Limited (TEVA) Morgan Stanley 21st Annual Global Healthcare Conference 2023 (Transcript)Seeking Alpha • 09/11/23
Teva to Present at the 21st Annual Morgan Stanley Global Healthcare ConferenceBusiness Wire • 09/06/23
Teva to Present Data for AUSTEDO® XR (deutetrabenazine) Extended-Release Tablets, AUSTEDO® (deutetrabenazine) Tablets and UZEDY™ (risperidone) Extended-Release Injectable Suspension at Psych Congress 2023Business Wire • 09/06/23
Alkermes shares surge after settlement with Teva on alcohol dependence treatmentMarket Watch • 08/30/23
The Mighty Teva Pharmaceutical: Unveiling A Bullish Scenario You Must ConsiderSeeking Alpha • 08/26/23
TEVA to Pay $225 Million to Settle Price-Fixing Charges (Revised)Zacks Investment Research • 08/23/23